Edition:
United Kingdom

Achaogen Inc (AKAO.OQ)

AKAO.OQ on NASDAQ Stock Exchange Global Market

4.12USD
4:36pm BST
Change (% chg)

$0.01 (+0.24%)
Prev Close
$4.11
Open
$4.12
Day's High
$4.23
Day's Low
$4.08
Volume
34,788
Avg. Vol
287,797
52-wk High
$15.00
52-wk Low
$3.33

Select another date:

Tue, Jun 26 2018

Achaogen's antibiotic gets FDA nod for urinary tract infections

June 26 The U.S. Food and Drug Administration approved Achaogen Inc's antibiotic to treat adults with complicated urinary tract infections, the company said on Tuesday.

BRIEF-Achaogen Q1 loss per share $1.06

* ACHAOGEN REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Achaogen Says FDA Advisory Committee Voted In Favor Of Plazomicin For Urinary Tract Infections

* ACHAOGEN ANNOUNCES FDA ADVISORY COMMITTEE VOTED UNANIMOUSLY IN FAVOR OF PLAZOMICIN FOR TREATMENT OF ADULTS WITH COMPLICATED URINARY TRACT INFECTIONS Source text for Eikon: Further company coverage:

BRIEF-Achaogen Stock Trading Halted Today

* ACHAOGEN STOCK TRADING HALTED TODAY Source text for Eikon: Further company coverage:

Select another date: